Gastrointestinal cancer1（肝胆膵）｜司会・講師のご紹介

Gastrointestinal cancer1（肝胆膵）｜Disccusion

解説【LBA3】Transarterial Chemoembolization (TACE) With or Without Lenvatinib (len) + Pembrolizumab (pembro) for Intermediate-Stage Hepatocellular Carcinoma (HCC): Phase 3 LEAP-012 Study

梅本 久美子　Umemoto Kumiko
（聖マリアンナ医科大学 臨床腫瘍学講座）

解説【LBA39】Updated efficacy and safety data from IMbrave050: Phase 3 study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)

梅本 久美子　Umemoto Kumiko
（聖マリアンナ医科大学 臨床腫瘍学講座）

解説【LBA62】Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): results from the randomized phase II trial PANDAS/PRODIGE 44.

梅本 久美子　Umemoto Kumiko
（聖マリアンナ医科大学 臨床腫瘍学講座）